Results 111 to 120 of about 12,760 (216)

Candidiasis vulvovaginal [PDF]

Revista chilena de infectología, 2008
openaire   +3 more sources

The role of L-type amino acid transporter 1 in the pathogenicity of Candida albicans

Microbiology Spectrum
Our recent study showed that lat1, which encodes L-type amino acid transporter 1 (Lat1) was centrally positioned in the gene co-expression network of a Candida albicans (C. albicans) infection model of cell culture and suggested that this gene might play
Yibing Lan, Cheng Wu, Peng Du, Jie Jiao, Chunming Li, Ketan Chu, Tao Zhang, Peiqiong Chen, An Li, Wenxian Xu, Xinyi Ying, Jianhong Zhou, Wenlong Lin, Linjuan Ma, Yizhou Huang   +14 more
doaj   +1 more source

Impacto dos fungos na saúde pública [PDF]

, 2014
Grande parte da população já sofreu de infeções fúngicas superficiais facilmente tratáveis. Contudo, milhões de indivíduos são vítimas de infeções fúngicas invasivas potencialmente fatais, de difícil diagnóstico e tratamento.
Cegonho, Sara, Rodrigues, Francisco
core  

The burden of serious fungal infections in Portugal [PDF]

, 2015
Using published data, we were able to estimate the incidence or prevalence of the above referred fungal infections and ~194 293 (1.8%) people in Portugal suffer from those fungal infections each ...
Denning, D., Pais, C., Sabino, Raquel, Veríssimo, Cristina   +3 more
core  

UJI BANDING EFEKTIVITAS BUGENFIL (Bougainvillea glabra Choicy.) 100% DAN KETOKONAZOL 2 % SECARA INVITRO TERHADAP PERTUMBUHAN Candida albicans PADA KANDIDIASIS VAGINALIS [PDF]

, 2006
Background: Candidiasis is infection which cause of Candida. Ketoconazole is an effective antifungal. Bougainvillea glabra Choicy. is an traditional drug to treatment of leucorrhea.
Setiawati, Erna
core  

Comparison of clinical and paraclinical diagnosis of vulvovaginal candidiasis in females referred to hospitals in Hamedan city

Medical Laboratory Journal, 2015
Background and Objective: Vulvovaginal candidiasis (VVC) often refers to yeast infection, which is a common gynecologic problem, affecting 75% of women during their lifetimes.
Habibipour, R
doaj  

Vulvovaginal candidiasis

BMJ, 2002
openaire   +5 more sources

State-of-the-Art Review: Managing Vulvovaginal Candidiasis. [PDF]

Clin Infect Dis
Rautemaa-Richardson R, Sobel JD, Stone N, De Seta F, Cassone A, Vieira-Baptista P, Comar M, Warris A, Roselletti E.   +8 more
europepmc   +1 more source

Discovery of a novel orthototivirus-like virus in patients with vulvovaginal candidiasis. [PDF]

Front Cell Infect Microbiol
Dai Z, Lu Q, Sun M, Chen H, Jiang Y, Yu T, Wang Z, Wang Y, Zhu R.   +8 more
europepmc   +1 more source

Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents. [PDF]

J Fungi (Basel)
Quindós G, De-la-Pinta I, Marcos-Arias C, Jauregizar N, Sevillano E, Madariaga L, Eraso E.   +6 more
europepmc   +1 more source